Combinostics at AAIC 2022
July 31 – August 3, 2022 | San Diego, CA
Did you miss our team at the 2022 Alzheimer’s Association International Conference® or want to discuss our products further? Schedule some time to learn more about our cNeuro® suite, including the cMRI™ and cDSI™ applications, industry-first Dementia Differential Analysis report, and new clinically focused cMRI reports for dementia, multiple sclerosis, traumatic brain injuries, and epilepsy. Our complete AI software solution supports entire patient care pathways of major neurological disorders, including early detection, differentiation of diagnosis, treatment planning, and monitoring.
Join presentations of our research at AAIC 2022.
Automated detection of lacunar infarcts from MRI images
Association between 10-year cardiovascular mortality-risk and neuroimaging biomarkers in the FINGER trial
Combinostics co-author: Jyrki Lötjönen, CSO
Optimizing cCOG, a web-based tool, to detect dementia with Lewy bodies
Combinostics co-authors: Antti Tolonen, Senior Imaging Scientist; Jyrki Lötjönen, CSO
Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.
Our cNeuro® suite puts the focus on patients by providing clinicians with objective, systematic insights for confident, evidence-based diagnostic and management decisions.
Patient data from multiple sources are integrated and compared with data from previous patients and healthy controls: demographic information, imaging (cMRI) and other biomarkers, clinical characteristics, and neuropsychology tests.
Applications in the cNeuro® suite:
Our AI-driven software tools support early detection, differential diagnosis, prediction of progression, and monitoring of neurodegenerative disorders.
cMRI provides fully automated brain MRI quantification for increased throughput, greater objectivity, and high-quality reporting for improved patient care.